Dositicon Co., Ltd. Hits Day Low of CNY 145.50 Amid Price Pressure

Dositicon Co., Ltd. experienced a notable decline today, with the stock dropping by 3.16% to touch an intraday low of CNY 145.50. This performance comes amid a broader market context where the China Shanghai Composite index saw a slight increase of 0.25%. Despite today's downturn, Dosilicon has shown significant growth over the past year, boasting an impressive 364.6% increase in stock value, far surpassing the 22.3% gain of the China Shanghai Composite. Over the last three years, the company has delivered a remarkable 421.46% return, indicating strong long-term performance relative to the market. However, the company faces challenges, including a low Return on Capital Employed (ROCE) of 18.97%, reflecting limited profitability per unit of capital. Additionally, Dosilicon has reported a concerning annual decline in net sales of 16.05% and a drastic drop in operating profit of 179.80% over the past five years. Despite these challenges, the company has declared positive results for the last three consecutive quarters, with operating cash flow reaching its highest at CNY -145.8 million and a significant reduction in raw material costs.